Materialise NV (MTLS)vsZepp Health Corp (ZEPP)
MTLS
Materialise NV
$5.49
+4.97%
TECHNOLOGY · Cap: $310.58M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Materialise NV generates 3% more annual revenue ($267.63M vs $258.90M). MTLS leads profitability with a 2.9% profit margin vs -15.5%. MTLS earns a higher WallStSmart Score of 51/100 (C-).
MTLS
Buy51
out of 100
Grade: C-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+74.0%
Fair Value
$21.19
Current Price
$5.49
$15.70 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 112.8% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
ROE of 3.1% — below average capital efficiency
2.9% margin — thin
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MTLS
The strongest argument for MTLS centers on Price/Book, EPS Growth, Debt/Equity. PEG of 1.26 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : MTLS
The primary concerns for MTLS are P/E Ratio, Market Cap, Return on Equity. Thin 2.9% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
MTLS profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MTLS scores higher overall (51/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Materialise NV
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Materialize NV offers additive manufacturing and medical software and 3D printing services in the Americas, Europe, Africa, and Asia-Pacific. The company is headquartered in Leuven, Belgium.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?